ATE533489T1 - Behandlung von multiplem myelom - Google Patents

Behandlung von multiplem myelom

Info

Publication number
ATE533489T1
ATE533489T1 AT07846860T AT07846860T ATE533489T1 AT E533489 T1 ATE533489 T1 AT E533489T1 AT 07846860 T AT07846860 T AT 07846860T AT 07846860 T AT07846860 T AT 07846860T AT E533489 T1 ATE533489 T1 AT E533489T1
Authority
AT
Austria
Prior art keywords
multiple myeloma
treatment
subject
administering
treating
Prior art date
Application number
AT07846860T
Other languages
English (en)
Inventor
Michel Jourdan
Michel Dreano
Bernard Klein
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of ATE533489T1 publication Critical patent/ATE533489T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07846860T 2006-11-27 2007-11-27 Behandlung von multiplem myelom ATE533489T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86112006P 2006-11-27 2006-11-27
US90413807P 2007-02-28 2007-02-28
PCT/EP2007/010299 WO2008064866A1 (en) 2006-11-27 2007-11-27 Treatment for multiple myeloma

Publications (1)

Publication Number Publication Date
ATE533489T1 true ATE533489T1 (de) 2011-12-15

Family

ID=39157918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07846860T ATE533489T1 (de) 2006-11-27 2007-11-27 Behandlung von multiplem myelom

Country Status (12)

Country Link
US (1) US20100069316A1 (de)
EP (1) EP2139482B1 (de)
JP (1) JP2010510971A (de)
KR (1) KR20090093965A (de)
AT (1) ATE533489T1 (de)
AU (1) AU2007324850A1 (de)
CA (1) CA2669128C (de)
EA (1) EA200970512A1 (de)
ES (1) ES2377717T3 (de)
IL (1) IL198901A0 (de)
MX (1) MX2009005649A (de)
WO (1) WO2008064866A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011260323A1 (en) 2010-06-04 2012-11-15 F. Hoffmann-La Roche Ag Aminopyrimidine derivatives as LRRK2 modulators
DK2638031T3 (en) 2010-11-10 2017-12-11 Genentech Inc PYRAZOLAMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS
EA201391591A1 (ru) * 2011-05-02 2014-12-30 Им Байосайенсиз Аустралиа Пти Лтд. Лечение множественной миеломы
IL308807B2 (en) * 2012-04-13 2025-08-01 Epizyme Inc Combination therapy for treating cancer
KR101471273B1 (ko) * 2013-01-29 2014-12-11 인제대학교 산학협력단 Ｓｏｄ２를 포함하는 보르테조밉 내성 진단용 바이오 마커 조성물 및 이를 이용한 진단 키트
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
TW202100520A (zh) 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
WO2020223558A1 (en) 2019-05-01 2020-11-05 Incyte Corporation Tricyclic amine compounds as cdk2 inhibitors
TW202115024A (zh) 2019-08-14 2021-04-16 美商英塞特公司 作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
CN119930610A (zh) 2019-10-11 2025-05-06 因赛特公司 作为cdk2抑制剂的双环胺
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618630B2 (en) * 1998-09-14 2009-11-17 Board Of Regents, The University Of Texas System Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
US7129242B2 (en) * 2000-12-06 2006-10-31 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
EP1364949A4 (de) * 2001-02-02 2005-11-23 Takeda Pharmaceutical Jnk inhibitor
US6864047B2 (en) * 2001-03-29 2005-03-08 Mayo Foundation For Medical Education And Research IL1-β: a new target for myeloma therapy
EP1404669A2 (de) * 2001-05-16 2004-04-07 Vertex Pharmaceuticals Incorporated Heterocyclisch substituierte pyrazole als inhibitoren von src und anderen protein kinasen

Also Published As

Publication number Publication date
IL198901A0 (en) 2010-02-17
ES2377717T3 (es) 2012-03-30
EA200970512A1 (ru) 2009-12-30
WO2008064866A1 (en) 2008-06-05
CA2669128C (en) 2011-07-12
US20100069316A1 (en) 2010-03-18
AU2007324850A2 (en) 2009-07-02
CA2669128A1 (en) 2008-06-05
EP2139482A1 (de) 2010-01-06
WO2008064866A8 (en) 2008-10-02
JP2010510971A (ja) 2010-04-08
AU2007324850A1 (en) 2008-06-05
KR20090093965A (ko) 2009-09-02
MX2009005649A (es) 2009-06-08
EP2139482B1 (de) 2011-11-16

Similar Documents

Publication Publication Date Title
ATE533489T1 (de) Behandlung von multiplem myelom
EA201290677A1 (ru) Соединения обратного амида в качестве ингибиторов протеиндеацетилазы и способы их применения
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
UA110338C2 (xx) Хімічні сполуки
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
EA201290919A1 (ru) Индазольные соединения и их применение
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA201300860A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA201200917A1 (ru) Пролекарства ингибиторов плазменного калликреина
EA201200373A1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
EA201100447A1 (ru) Органические соединения
EA201170344A1 (ru) Азаиндольные ингибиторы iap
CY1115262T1 (el) Ανταγωνιστες trpv1 και χρησεις αυτων
EA201890768A2 (ru) Лечение злокачественной опухоли ингибиторами tor-киназы
EA201391591A1 (ru) Лечение множественной миеломы
EA201291099A1 (ru) Новые иммуномодуляторные и противовоспалительные соединения
GEP20146131B (en) Carbazole compounds and therapeutic uses thereof
EA201170832A1 (ru) Пуриновые соединения
EA200971141A1 (ru) Соединения, активирующие теломеразу, и способы их применения
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
UA107562C2 (uk) Спосіб лікування псоріазу
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
EA201100874A1 (ru) Соединения для лечения рака
PH12013500644A1 (en) Co-crystals and salts of ccr3-inhibitors